Tudor Investment Corp’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-28,875
| Closed | -$455K | – | 2047 |
|
|
2023
Q3 | $455K | Buy |
+28,875
| New | +$455K | ﹤0.01% | 1145 |
|
|
2023
Q1 | – | Sell |
-32,382
| Closed | -$947K | – | 2090 |
|
|
2022
Q4 | $947K | Buy |
32,382
+4,921
| +18% | +$144K | 0.02% | 868 |
|
|
2022
Q3 | $726K | Buy |
27,461
+4,668
| +20% | +$123K | 0.02% | 958 |
|
|
2022
Q2 | $1.01M | Buy |
+22,793
| New | +$1.01M | 0.03% | 802 |
|
|
2020
Q1 | – | Sell |
-7,425
| Closed | -$446K | – | 1379 |
|
|
2019
Q4 | $446K | Sell |
7,425
-13,353
| -64% | -$802K | 0.02% | 752 |
|
|
2019
Q3 | $1.18M | Buy |
20,778
+10,875
| +110% | +$615K | 0.04% | 439 |
|
|
2019
Q2 | $551K | Sell |
9,903
-1,967
| -17% | -$109K | 0.02% | 674 |
|
|
2019
Q1 | $599K | Sell |
11,870
-9,374
| -44% | -$473K | 0.02% | 631 |
|
|
2018
Q4 | $856K | Buy |
21,244
+8,667
| +69% | +$349K | 0.02% | 426 |
|
|
2018
Q3 | $872K | Buy |
12,577
+8,544
| +212% | +$592K | 0.02% | 497 |
|
|
2018
Q2 | $305K | Buy |
+4,033
| New | +$305K | 0.01% | 799 |
|
|
2016
Q3 | – | Sell |
-7,000
| Closed | -$272K | – | 1651 |
|
|
2016
Q2 | $272K | Buy |
7,000
+1,600
| +30% | +$62.2K | 0.01% | 1070 |
|
|
2016
Q1 | $219K | Sell |
5,400
-1,067
| -16% | -$43.3K | 0.01% | 1231 |
|
|
2015
Q4 | $573K | Buy |
+6,467
| New | +$573K | 0.02% | 651 |
|